NEWTOWN, Penn.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced the release of BioClinica OnPoint CTMS and noted a surge in clinical trial management system (CTMS) demand. OnPoint is the new release of the CTMS platform that BioClinica acquired from TranSenda in 2010.
